Publications by authors named "Qingwei Luo"

Australia's National Lung Cancer Screening Program will commence in July 2025, targeted at individuals aged 50-70 years with a 30 pack-year smoking history (equivalent to 20 cigarettes per day for 30 years), who either currently smoke or have quit within the past 10 years. We forecasted the number of screening-eligible individuals over the first 5 years of the program using data from the 2019 National Drug Strategy Household Survey and the 2022 Australian Bureau of Statistics population projections. Multiple imputation integrated with predictive modelling of future or unmeasured smoking characteristics was used to address missing data and, simultaneously, to project individuals' smoking histories to 2030.

View Article and Find Full Text PDF

Background: Colon cancer (CC) is a highly prevalent malignancy that contributes significantly to global morbidity and mortality. The polycomb group ring finger 2 (PCGF2) has been identified as a relevant factor influencing the outcomes of CC. At the same time, the centromere-associated protein E (CENPE) is implicated in promoting carcinogenesis and adversely affecting the survival of tumor patients.

View Article and Find Full Text PDF

Objective: The objective of this study was to estimate the association between vaping and subsequent initiation of smoking among Australian adolescents and explore the impact of design and analytical methods in previous studies.

Methods: We conducted a retrospective cohort analysis of cross-sectional data from 5114 Australian adolescents aged 14-17 recalling information on smoking and vaping initiation from age 12 to 17. The outcome was smoking initiation, analysed with negative-binomial regression to estimate incidence rate ratios (IRRs) for vape status (ever-vaped vs never-vaped) as a time-varying exposure.

View Article and Find Full Text PDF
Article Synopsis
  • Australia has seen rising rates of multiple myeloma (MM) incidence and mortality, prompting research into survival trends across different treatment eras from 1985 to 2015.
  • A study of over 11,500 individuals showed a marked improvement in 5-year relative survival rates, increasing from 31.0% in 1985-1995 to 56.1% in 2008-2015, especially among those diagnosed under 70 years old.
  • Despite advancements in treatment leading to better overall survival, older patients (70+) still face poorer outcomes, highlighting the need for ongoing research and targeted therapies for this age group.
View Article and Find Full Text PDF
Article Synopsis
  • - The study analyzes changes in multiple myeloma incidence and mortality rates in Australia from 1982-2018 and makes projections for 2019-2043 using population-based statistical models.
  • - Results show that the incidence of multiple myeloma increased by 1.9% annually from 2006-2018, while the mortality rate decreased by 0.4% annually from 1990-2018.
  • - Projections indicate a 14.9% increase in incidence and a 27.5% decrease in mortality rates by 2043, with a significant rise in the number of people living with multiple myeloma expected to reach 27,093, up from 10,288
View Article and Find Full Text PDF

Background: Weighting can improve study estimate representativeness. We examined the impact of weighting on associations between participants' characteristics and cancer, cardiovascular and all-cause mortality in the Australian 45 and Up Study cohort.

Methods: Raking weighted cohort data to the 2006 Australian population for seven sociodemographic characteristics.

View Article and Find Full Text PDF
Article Synopsis
  • The study projects premature mortality rates in Australia until 2044, revealing a significant decrease in age-standardized rates but an increase in total premature deaths due to an aging population.
  • It found a 44.4% decrease in rates from 1990-1994 to 2015-2019, with predictions of a 12.7% further decline by 2044, yet total deaths are expected to rise from 272,815 to 334,894.
  • Cancer is forecasted to remain the leading cause of premature deaths, emphasizing the need for targeted public health strategies in Australia.
View Article and Find Full Text PDF

Guidelines for prostate specific antigen (PSA) testing in Australia recommend that men at average risk of prostate cancer who have been informed of the benefits and harms, and who decide to undergo regular testing, should be offered testing every 2 years from 50 to 69 years. This study aimed to estimate the benefits and harms of regular testing in this context. We constructed Policy1-Prostate, a discrete event microsimulation platform of the natural history of prostate cancer and prostate cancer survival, and PSA testing patterns and subsequent management in Australia.

View Article and Find Full Text PDF

Problems paying medical bills may affect HIV outcomes among people with HIV (PWH), thus limiting progress toward achieving national HIV prevention goals. We analyzed nationally representative data from CDC's Medical Monitoring Project collected during 6/2018-5/2020. Among 8,108 PWH, we reported weighted percentages of characteristics and examined associations between problems paying medical bills and clinical outcomes using prevalence ratios with predicted marginal means, adjusting for potential confounding.

View Article and Find Full Text PDF

Daytime HONO photolysis is an important source of atmospheric hydroxyl radicals (OH). Knowledge of HONO formation chemistry under typical haze conditions, however, is still limited. In the Multiphase chemistry experiment in Fogs and Aerosols in the North China Plain in 2018, we investigated the wintertime HONO formation and its atmospheric implications at a rural site Gucheng.

View Article and Find Full Text PDF

Background: The benefits and harms of breast screening may be better balanced through a risk-stratified approach. We conducted a systematic review assessing the accuracy of questionnaire-based risk assessment tools for this purpose.

Methods: Population: asymptomatic women aged ≥40 years; Intervention: questionnaire-based risk assessment tool (incorporating breast density and polygenic risk where available); Comparison: different tool applied to the same population; Primary outcome: breast cancer incidence; Scope: external validation studies identified from databases including Medline and Embase (period 1 January 2008-20 July 2021).

View Article and Find Full Text PDF

Research that explores the intra-racial socio-demographic and clinical characteristics associated with perceived discrimination in healthcare settings in the US is lacking. We examined the prevalence of self-reported discrimination in HIV care settings during the past 12 months among Black persons from a nationally representative sample of US adults with diagnosed HIV collected 6/2018-5/2019. We assessed the prevalence of self-reported discrimination in HIV care settings during the past 12 months, perceived reasons for discrimination, and factors associated with discrimination among Black persons with diagnosed HIV ( = 1,631).

View Article and Find Full Text PDF
Article Synopsis
  • The study highlights the health challenges faced by transgender women with HIV, including high rates of HIV stigma, homelessness, and mental health issues.
  • Approximately 46% identified as Black, 67% lived below the poverty line, with significant reports of depression and violence in their lives.
  • The findings suggest a critical need for enhanced support services and strategies to combat stigma and discrimination in healthcare for this population.
View Article and Find Full Text PDF

Objectives: We examined sociodemographic, clinical, and behavioral factors associated with previous incarceration among people with diagnosed HIV to inform HIV care efforts for this population.

Methods: We used 2015-2017 data from a cross-sectional, nationally representative sample of US adults with diagnosed HIV (N = 11 739). We computed weighted percentages and 95% CIs to compare the characteristics of people with HIV incarcerated in the past 12 months (ie, recently) with people with HIV not recently incarcerated.

View Article and Find Full Text PDF

Background: While many high-income countries including Australia have successfully implemented a range of tobacco control policies, smoking remains the leading preventable cause of cancer death in Australia. We have projected Australian mortality rates for cancer types, which have been shown to have an established relationship with cigarette smoking and estimated numbers of cancer deaths attributable to smoking to 2044.

Methods: Cancer types were grouped according to the proportion of cases currently caused by smoking: 8%-30% and >30%.

View Article and Find Full Text PDF
Article Synopsis
  • Cancer Projections
  • : The study aims to project cancer incidence and mortality rates in Australia from 2020 to 2044, estimating new cases and deaths for all cancers combined and 21 specific types, considering factors like smoking and screening rates.
  • Methodology
  • : A statistical modeling approach was employed, using historical cancer data and tailored models to predict future trends, while also assessing the impact of COVID-19 treatment delays on colorectal cancer mortality.
  • Key Findings
  • : Projections suggest that the incidence rate of all cancers combined for males will decrease by 2044, while females' incidence rate will remain stable; however, mortality trends were not fully detailed in the provided text.
View Article and Find Full Text PDF

Background: Health surveys are commonly somewhat non-representative of their target population, potentially limiting the generalisability of prevalence estimates for health/behaviour characteristics and disease to the population. To reduce bias, weighting methods have been developed, though few studies have validated weighted survey estimates against generally accepted high-quality independent population benchmark estimates.

Methods: We applied post-stratification and raking methods to the Australian 45 and Up Study using Census data and compared the resulting prevalence of characteristics to accepted population benchmark estimates and separately, the incidence rates of lung, colorectal, breast and prostate cancer to whole-of-population estimates using Standardised Incidence Ratios (SIRs).

View Article and Find Full Text PDF
Article Synopsis
  • The study analyzed trends in prostate cancer incidence, mortality rates, and 5-year relative survival in Australia, focusing on PSA screening and radical prostatectomy use.
  • Localized prostate cancer incidence rates showed a significant rise in 1994 and 2008, followed by a decline post-2008; meanwhile, survival rates improved from 58.4% to 91.3%.
  • The overall mortality rates for prostate cancer have decreased since the 1990s, suggesting that less frequent PSA screening has not negatively impacted patient outcomes.
View Article and Find Full Text PDF
Article Synopsis
  • A study analyzed mortality projections for colon and rectal cancers in Australia using data from the New South Wales Cancer Registry (NSWCR) instead of previous predictions from the Australian Bureau of Statistics (ABS), which had inconsistencies.
  • The projections indicate a steady decline in colon cancer mortality rates for both males (from 7.0 to 4.7 per 100,000) and females (from 5.3 to 3.2 per 100,000) from 2015 to 2040.
  • For rectal cancer, a similar decline is expected, with rates dropping from 4.9 to 3.7 per 100,000 in males and from 2.6 to 2
View Article and Find Full Text PDF

Background: While many past studies have constructed projections of future lung cancer rates, little is known about their consistency with the corresponding observed data for the time period covered by the projections. The aim of this study was to assess the agreement between previously published lung cancer incidence and/or mortality rate projections and observed rates.

Methods: Published studies were included in the current study if they projected future lung cancer rates for at least 10 years beyond the period for which rates were used to obtain the projections, and if more recent observed rates for comparison covered a minimum of 10 years from the beginning of the projection period.

View Article and Find Full Text PDF

Objective: A previous Australian study compared the observed numbers of cancer cases and deaths in 2007 with the expected numbers based on 1987 rates. This study examines the impact of cancer rate changes over the 20-year period 1996-2015, for people aged under 75 years.

Results: The overall age-standardised cancer incidence rate increased from 350.

View Article and Find Full Text PDF

Background: In a previous Cochrane Review, we found that for women with metastatic breast cancer unselected for triple-negative disease, there is little or no survival benefit and excess toxicity from platinum-based regimens. In subgroup analyses, however, we found preliminary low-quality evidence of a survival benefit from platinum-based regimens for women with metastatic triple-negative breast cancer (mTNBC). This review updates the evidence from the mTNBC subgroup analyses in the previous Cochrane Review.

View Article and Find Full Text PDF

Amino acids are important water-soluble nitrogen-containing compounds in atmospheric aerosols. They can be involved in cloud formation due to their hygroscopicity and have significant influences on the hygroscopicity of inorganic compounds, which have not yet been well characterized. In this work, the hygroscopic properties of three amino acids, including aspartic acid, glutamine, and serine, as well as their mixtures with ammonium sulfate (AS) were investigated using a hygroscopicity tandem differential mobility analyzer (HTDMA) system.

View Article and Find Full Text PDF